ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $310,000 | -52.6% | 7,391 | -48.6% | 0.20% | -26.0% |
| Q4 2019 | $654,000 | -0.8% | 14,391 | 0.0% | 0.26% | -4.3% |
| Q3 2019 | $659,000 | -38.7% | 14,391 | -21.5% | 0.28% | -38.9% |
| Q2 2019 | $1,075,000 | -34.6% | 18,332 | -50.0% | 0.45% | -30.8% |
| Q1 2019 | $1,644,000 | +6.0% | 36,676 | -7.9% | 0.66% | -10.2% |
| Q4 2018 | $1,551,000 | -10.1% | 39,828 | +6.2% | 0.73% | +30.2% |
| Q3 2018 | $1,725,000 | +14.0% | 37,491 | +8.1% | 0.56% | -1.2% |
| Q2 2018 | $1,513,000 | +47.0% | 34,691 | +33.2% | 0.57% | +33.7% |
| Q1 2018 | $1,029,000 | +51.1% | 26,042 | +29.9% | 0.42% | +56.5% |
| Q4 2017 | $681,000 | +35.9% | 20,042 | +2.0% | 0.27% | +26.6% |
| Q3 2017 | $501,000 | – | 19,642 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |